A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study
Journal article published in 2020 by
Tanguy Y. Seiwert 
,
Sara Kochanny ,
Kevin Wood,
Francis P. Worden,
Douglas Adkins ,
James L. Wade,
Bethany G. Sleckman,
Daniel Anderson,
Ryan J. Brisson ,
Theodore Karrison,
Walter M. Stadler ,
Everett E. Vokes
,
Sara Kochanny ,
Kevin Wood,
Francis P. Worden,
Douglas Adkins ,
James L. Wade,
Bethany G. Sleckman,
Daniel Anderson,
Ryan J. Brisson ,
Theodore Karrison,
Walter M. Stadler ,
Everett E. Vokes
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 